SOPHiA GENETICS SA (NASDAQ:SOPH) is one of the 8 Best Healthcare AI Stocks to Buy According to Analysts. On April 15, 2026, BTIG raised its price target on SOPHiA GENETICS SA (NASDAQ:SOPH) to $8 from $7 and maintained a Buy rating. The firm said management “signaled confidence across the business” following investor meetings with President and incoming CEO Ross Muken, CFO George Cardoza, and Head of Strategy Kellen Sanger. In March, SOPHiA GENETICS SA (NASDAQ:SOPH) reported Q4 EPS of (28c) compared to ( ...